SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042978
Filing Date
2019-11-12
Accepted
2019-11-12 16:40:44
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-10q_20190930.htm   iXBRL 10-Q 3260829
2 EX-10.3 adpt-ex103_547.htm EX-10.3 169598
3 EX-31.1 adpt-ex311_252.htm EX-31.1 24797
4 EX-31.2 adpt-ex312_253.htm EX-31.2 26206
5 EX-32.1 adpt-ex321_251.htm EX-32.1 11637
6 EX-32.2 adpt-ex322_250.htm EX-32.2 13092
  Complete submission text file 0001564590-19-042978.txt   10273445

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA adpt-20190930.xsd EX-101.SCH 54605
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adpt-20190930_cal.xml EX-101.CAL 52345
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adpt-20190930_def.xml EX-101.DEF 193788
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adpt-20190930_lab.xml EX-101.LAB 437011
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adpt-20190930_pre.xml EX-101.PRE 348289
57 EXTRACTED XBRL INSTANCE DOCUMENT adpt-10q_20190930_htm.xml XML 1992002
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 191210235
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences